| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 07/21/2011 | WO2011028043A3 Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same |
| 07/21/2011 | WO2010121212A3 Indoline scaffold shp-2 inhibitors and method of treating cancer |
| 07/21/2011 | US20110178311 Purification of Progesterone Receptor Modulators |
| 07/21/2011 | US20110178294 Novel carboxylic acid derivatives, their preparation and use |
| 07/21/2011 | US20110178293 Novel Oxazolidinone Derivatives with Cyclic Amidoxime or Cyclic Amidrazone and Pharmaceutical Compositions Thereof |
| 07/21/2011 | US20110178125 Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 07/21/2011 | US20110178123 Nonpeptide hiv-1 protease inhibitors |
| 07/21/2011 | US20110178101 Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents |
| 07/21/2011 | US20110178093 Tetrasubstituted pyridazines hedgehog pathway antagonists |
| 07/21/2011 | US20110178092 HIV-1 Protease Inhibitors |
| 07/21/2011 | US20110178091 Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders |
| 07/21/2011 | US20110178089 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds |
| 07/21/2011 | US20110178081 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/21/2011 | US20110178075 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 07/21/2011 | US20110178074 Antipathogenic benzamide compounds |
| 07/21/2011 | US20110178069 Inhibitors of interleukin-1 beta converting enzyme |
| 07/21/2011 | US20110178062 Indole and benzothiophene compounds as modulators of the histamine h3 receptor |
| 07/21/2011 | US20110178060 Nitrogen-containing heterocyclic compound and use of same |
| 07/21/2011 | US20110178053 Azacarboline derivatives, preparation method thereof and therapeutic use of same |
| 07/21/2011 | US20110178018 Novel selenium-containing compounds |
| 07/21/2011 | US20110178007 Spiro-imidazolone derivatives as glucagon receptor antagonists |
| 07/21/2011 | US20110177060 Iap bir domain binding compounds |
| 07/21/2011 | CA2786434A1 Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same |
| 07/21/2011 | CA2784769A1 Novel substituted triazole derivatives as gamma secretase modulators |
| 07/21/2011 | CA2784007A1 Pyrrolidine derivatives |
| 07/21/2011 | CA2782270A1 Methods for the preparation of indazole-3-carboxyclic acid and n-(s)-1-azabicyclo[2.2.2]oct-3-yl-1h-indazole-3-carboxamide hydrochloride salt |
| 07/20/2011 | EP2344479A2 1,2-benzisothiazolinone and isoindolinone derivatives |
| 07/20/2011 | EP2344478A2 Novel cc-1065 analogs and their conjugates |
| 07/20/2011 | EP2344476A2 Tricyclic carbamate jak inhibitors |
| 07/20/2011 | EP2344475A1 Quinazolinone, quinolone and related analogs as sirtuin modulators |
| 07/20/2011 | EP2344459A1 2,3-substituted indazole or 4,5,6,7-tetrahydro-indazoles as fxr modulators against dyslipidemia and related diseases |
| 07/20/2011 | EP2344458A1 Heteroaryls amide derivatives and their use as glucokinase activators |
| 07/20/2011 | EP2344456A1 Novel potassium channel blocker |
| 07/20/2011 | EP2344454A1 Antioxidant compounds and methods of their use |
| 07/20/2011 | EP2344453A2 Activators of human pyruvate kinase |
| 07/20/2011 | EP2344157A1 Novel inhibitors |
| 07/20/2011 | EP2125788B9 Heterocyclic compounds, compositions comprising them and methods of their use |
| 07/20/2011 | EP2097406B1 Hydantoin derivatives used as mmp inhibitors |
| 07/20/2011 | EP1605936B1 Aryl spirohydantoin cgrp receptor antagonists |
| 07/20/2011 | EP1525265B1 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups |
| 07/20/2011 | CN1950360B Substituted pyrrole-2, 5-diones as protein kinase c inhibitors |
| 07/20/2011 | CN1882578B 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors |
| 07/20/2011 | CN102131813A Biocatalytic processes for preparation of substantially stereomerically pure fused bicyclic proline compounds |
| 07/20/2011 | CN102131802A New heterocyclic carboxamides for use as thrombin inhibitors |
| 07/20/2011 | CN102131788A Compounds and compositions as protein kinase inhibitors |
| 07/20/2011 | CN102131777A Piperidyl acrylamide antogonists of CCR2 |
| 07/20/2011 | CN102131774A Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent |
| 07/20/2011 | CN102127059A Near-infrared fluorescent probe with maximum Stoke displacement |
| 07/20/2011 | CN102127058A Pyrimidine derivatives for the treatment of abnormal cell growth |
| 07/20/2011 | CN102127057A Dipeptidyl peptidase inhibitors |
| 07/20/2011 | CN102127056A Tubulin inhibitors |
| 07/20/2011 | CN102127053A Dipeptidyl peptidase inhibitors |
| 07/20/2011 | CN102127023A 7-membered ring compound, process for producing the same, and use thereof |
| 07/20/2011 | CN102127019A Geldanamycin derivative, preparation thereof and medicament application thereof |
| 07/20/2011 | CN102126963A Spirobifluorene amido compound and preparation method thereof |
| 07/20/2011 | CN101735161B Preparation method of rizatriptan benzoate intermediate |
| 07/20/2011 | CN101580489B Nitrogenous heterocyclic ring compound and preparation method and application thereof |
| 07/20/2011 | CN101544614B Phosphodiesterase III inhibitor, method for preparing same and medicinal application thereof |
| 07/20/2011 | CN101481353B Tetrahydro indazolone or tetrahydro indolone substituted indazole derivative and salt thereof |
| 07/20/2011 | CN101270342B Tumour targeting fluorescent probe and application in tumour NO test |
| 07/19/2011 | US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3 |
| 07/19/2011 | US7981900 2-phenyl pyrimidines which are tubulin inhibitors |
| 07/19/2011 | US7981897 Crystal form of (3-cyano-1H-Indo1-7-yl)-[4-(4-fluorophenethyl)piperazin-1-yl]methanone, hydrochloride |
| 07/19/2011 | US7981896 Pyrazoles for the treatment of obesity and other CNS disorders |
| 07/19/2011 | US7981889 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis |
| 07/19/2011 | US7981882 e.g. 7-Chloro-3-(2,2,2-trifluoroacetyl)-6-trifluoromethanesulfonyloxy-2,3,4,5-tetrahydro-1H-benzo[d]azepine; antidepressant, anxiolytic agent; obesity, obsessive/compulsive disorder |
| 07/19/2011 | CA2599415C Stable micronized candesartan cilexetil and methods for preparing thereof |
| 07/19/2011 | CA2526663C Indole derivatives with apoptosis-inducing effect |
| 07/19/2011 | CA2476186C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/14/2011 | WO2011084962A1 Analogs of dehydrophenylahistins |
| 07/14/2011 | WO2011084642A1 Compound suitable for the treatment of synucleopathies |
| 07/14/2011 | WO2011083527A1 Dye for photoelectric conversion, semiconductor electrode, photoelectric conversion element, solar cell, and novel pyrroline compound |
| 07/14/2011 | WO2011083315A1 Compounds and their use |
| 07/14/2011 | WO2011083314A1 Benzazepine derivatives for the treatment of central nervous system disorders |
| 07/14/2011 | WO2011082519A1 Geldanamycin derivatives, preparation methods and uses thereof |
| 07/14/2011 | WO2011031111A3 Alkoxy indole-3-acetic acid derivative acting as ppar α/γ/δ agonists, preparation method thereof, and pharmaceutical composition containing same as active ingredient |
| 07/14/2011 | WO2011028507A3 Compositions, methods, and kits for determining an alkyl transferase |
| 07/14/2011 | US20110172434 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
| 07/14/2011 | US20110172417 Heterogeneous Copper Nanocatalyst and Manufacturing Methods Thereof |
| 07/14/2011 | US20110172415 Nitrogen-containing heterocycle derivatives substituted with cyclic group |
| 07/14/2011 | US20110172248 Substituted heteroarylamide analogs as mglur5 negative allosteric modulators and methods of making and using the same |
| 07/14/2011 | US20110172247 Substituted heteroarylamine carboxamide analogs as mglur5 negative allosteric modulators and methods of making and using the same |
| 07/14/2011 | US20110172244 Compounds and compositions as modulators of gpr119 activity |
| 07/14/2011 | US20110172238 Benzimidazole analogues for the treatment or prevention of flavivirus infections |
| 07/14/2011 | US20110172231 2,4- diaminopyrimidine derivatives |
| 07/14/2011 | US20110172230 Urea compound or salt thereof |
| 07/14/2011 | US20110172218 Cgrp antagonists |
| 07/14/2011 | US20110172212 Amine-based compound and use thereof |
| 07/14/2011 | US20110172207 Substituted pyrazolamides and their use |
| 07/14/2011 | US20110172206 Compositions and methods for treatment of neurodegenerative disease |
| 07/14/2011 | US20110172204 Compounds and their use |
| 07/14/2011 | US20110172195 Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance |
| 07/14/2011 | US20110171678 Modified carbocyanine dyes and their conjugates |
| 07/14/2011 | US20110171301 F, G, H, I and K Crystal Forms of Imatinib Mesylate |
| 07/14/2011 | US20110171171 Bridged secondary amines and use thereof as iap bir domain binding compounds |
| 07/14/2011 | US20110168343 Optical Brightening Compositions |
| 07/14/2011 | CA2784744A1 Compound |
| 07/13/2011 | EP2343291A1 3-(Indolyl)- or 3-(Azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment |
| 07/13/2011 | EP2343282A1 Diaminopyrimidines as P2X3 and P2X2/3 antagonists |
| 07/13/2011 | EP2343069A1 Heterocyclic aspartyl protease inhibitors |